Psychostimulants induce neuroadaptations in excitatory and fast inhibitory transmission in the ventral tegmental area (VTA). Mechanisms underlying drugevoked synaptic plasticity of slow inhibitory transmission mediated by GABA B receptors and G protein-gated inwardly rectifying potassium (GIRK/ Kir 3 ) channels, however, are poorly understood. Here, we show that 1 day after methamphetamine (METH) or cocaine exposure both synaptically evoked and baclofen-activated GABA B R-GIRK currents were significantly depressed in VTA GABA neurons and remained depressed for 7 days. Presynaptic inhibition mediated by GABA B Rs on GABA terminals was also weakened. Quantitative immunoelectron microscopy revealed internalization of GABA B1 and GIRK2, which occurred coincident with dephosphorylation of serine 783 (S783) in GABA B2 , a site implicated in regulating GABA B R surface expression. Inhibition of protein phosphatases recovered GABA B R-GIRK currents in VTA GABA neurons of METH-injected mice. This psychostimulant-evoked impairment in GABA B R signaling removes an intrinsic brake on GABA neuron spiking, which may augment GABA transmission in the mesocorticolimbic system.
INTRODUCTION
Changes in the motivation for drugs and natural rewards are central to the development of addiction (Koob and Volkow, 2010) . The mesocorticolimbic dopamine (DA) system is the major brain reward circuit involved in translating motivations into goal-directed behaviors. Within this system, natural rewards increase activity of the ventral tegmental area (VTA) DA neurons, which primarily project to the nucleus accumbens (NAc), amygdala, and medial prefrontal cortex (mPFC). Addictive drugs converge on the mesocorticolimbic DA system, however, producing long-lasting changes in DA levels and excitability of DA neurons (Koob and Volkow, 2010; Lü scher and Malenka, 2011) . One of the key pathways for controlling DA neuron excitability is through activation of a slow GABA-dependent inhibitory current, mediated by GABA B receptors (GABA B Rs) and G protein-gated inwardly rectifying potassium (GIRK/Kir 3 ) channels (Johnson and North, 1992; Cruz et al., 2004; Labouè be et al., 2007) and through an auto-inhibitory pathway mediated by D2 dopamine receptors (D2Rs) and GIRK channels (Johnson and North, 1992; Beckstead et al., 2004) . In vivo exposure to psychostimulants leads to reduced sensitivity of D2 autoreceptors and increased DA neuron excitability (White and Wang, 1984; Henry et al., 1989; White, 1996) , implicating GIRK channels in the response to addictive drugs (Lü scher and Slesinger, 2010) . Consistent with this, mice lacking GIRK channels self-administer less cocaine (Morgan et al., 2003) and show reduced withdrawal after chronic exposure to morphine (Cruz et al., 2008) . Furthermore, Girk2 transcripts in the mesocorticolimbic dopamine pathway are increased in some human cocaine addicts (Lehrmann et al., 2003) . Although GIRK channels are implicated in the response to addictive drugs, the cellular mechanisms underlying drug-evoked changes in GIRK signaling are not well understood.
Accumulating evidence suggests that acquisition of addictive behaviors is learned and, similar to other learning and memory models, involves persistent changes in synaptic strength within the reward circuit and changes in DA neuron signaling (Koob and Volkow, 2010 ; Lü scher and Malenka, 2011). Early drug-evoked neuroadaptations are thought to occur within the VTA and are critical for remodeling the reward circuit and facilitating the development of addiction. Lesion of VTA DA neurons blocks drug-dependent addictive behaviors (Roberts and Koob, 1982) . Neuro-adaptations that occur 24 hr following exposure to addictive drugs in vivo have been described. Systemic injection of a psychostimulant strengthens excitatory synapses in the VTA (White et al., 1995; Zhang et al., 1997; Ungless et al., 2001; Borgland et al., 2004; Argilli et al., 2008 ) through recruitment of GluA2-lacking AMPA receptors to the synapses (Bellone and Lü scher, 2006; Argilli et al., 2008) . Neuro-adaptations in fast GABA transmission have also been reported; fast inhibitory currents mediated by GABA A receptors are impaired 24 hr after a single injection of morphine (Nugent et al., 2007) , and the amplitudes of GABA-mediated synaptic currents are reduced in mice receiving several injections of cocaine (Liu et al., 2005) . Chronic amphetamine enhances GABA B receptor transmission in the VTA during early withdrawal, but the cellular mechanism underlying this change is unknown (Giorgetti et al., 2002) . Following chronic cocaine or morphine treatment, D1R stimulation decreases GABA B -GIRK currents in DA neurons, but this occurs from a change in presynaptic GABA release (Bonci and Williams, 1996) . In this study, we sought to characterize the early modulation of GABA B signaling by a single exposure to psychostimulants. We discovered that $24 hr following intraperitoneal (i.p.) injection of methamphetamine (METH) or cocaine, GABA B receptor signaling in VTA GABA neurons is strongly and persistently impaired. This drug-evoked depression of GABA B R-GIRK signaling involves dephosphorylation of the GABA B receptor and changes in GABA B R and GIRK channel trafficking. As a consequence, VTA GABA neuron firing is not affected by the GABA B R agonist baclofen, suggesting GABAergic function may be augmented in the VTA with psychostimulants.
RESULTS
Psychostimulant-Evoked Plasticity in GABA B R Signaling in VTA A single injection of psychostimulants enhances glutamatergic synaptic efficacy in the VTA 24 hr later (Ungless et al., 2001; Borgland et al., 2004; Argilli et al., 2008) . We examined whether a single injection of psychostimulant also alters GABA B R-GIRK signaling in the VTA. To test this, we injected C57BL/6 mice with methamphetamine (METH) at 2 mg/kg, a dose that elicits locomotor sensitization when administered repeatedly (Shimosato et al., 2001; Fukushima et al., 2007; Scibelli et al., 2011) and examined GABA B R-GIRK signaling in the VTA 24 hr later. We first investigated the synaptically activated GABA B R-GIRKs, commonly referred to as the slow inhibitory postsynaptic current (sIPSC), in acutely prepared VTA slices. High frequency (66 Hz) stimulation of GABA afferents induces a spillover of GABA that diffuses to perisynaptic GABA B receptors and elicits a slow outward K + current (sIPSC; Figure 1 ). The GABA B receptor antagonist, CGP 54626 (2 mM), inhibited the evoked current, confirming the identity of the GABA B sIPSC (Figure 1 ), similar to previous studies (Johnson and North, 1992; Bonci and Williams, 1996) . In DA neurons, the GABA B sIPSC did not significantly change 24 hr following METH, compared to saline injection ( Figures 1A and 1B) . By contrast, the sIPSC was significantly smaller in GABA neurons ( Figures 1D and 1E) . Moreover, the sIPSC in GABA neurons remained depressed for at least 7 days ( Figure 1E ). Examination of the paired-pulse ratio for the fast GABA A -mediated IPSC revealed no difference in either DA or GABA neurons ( Figures 1C and 1F) , suggesting that the depression of the sIPSC in GABA neurons was not due to the inability of GABA terminals to release GABA. To investigate the effects of METH on synaptic and extrasynaptic GABA B receptors, the GABA B receptor agonist baclofen The slow inhibitory postsynaptic current (sIPSC) recorded from DA (A) and GABA (D) neurons in the VTA 24 hr following a saline (0.9%) or METH (2 mg/kg) injection. The GABA B receptor antagonist CGP 54626 (2 mM) inhibited the sIPSC (light gray or light red trace). The GABA B R-sIPSC is reduced in the VTA GABA neuron 24 hr following METH injection. Scale bars: 5 pA, 200 ms. (B and E) Bar graphs show mean amplitudes for sIPSC following saline or METH (24 hr and 7 days later) in DA (B) (DA saline: 15.8 ± 1.5 pA; DA METH: 16.5 ± 2.8 pA; DA 7 days METH: 16.1 ± 2.0 pA) and GABA (E) neurons (GABA saline: 17.8 ± 2.6 pA; GABA METH: 0.7 ± 0.5 pA; GABA 7 days METH: 1.5 ± 1.0 pA). The sIPSC is significantly depressed 24 hr and 7 days following a single injection of METH in GABA neurons (**p < 0.05 [one-way ANOVA]). (C and F) Box plots show GABA A receptor-mediated IPSC paired-pulse ratio (PPR) plotted for DA (C) and GABA (F) neurons in saline and METH -injected mice (DA saline: 0.73 ± 0.10 pA; DA METH: 0.89 ± 0.09 pA; GABA saline: 1.20 ± 0.17 pA; GABA METH: 1.02 ± 0.11 pA (ns, ). Line shows mean. Insets show representative traces for each condition. Scale bars: 100 pA, 20 ms. N (number of recordings) indicated on all graphs. All bar graphs show mean ± SEM. was applied to the bath. As described previously (Labouè be et al., 2007) , saturating doses of baclofen (300 mM for DA and 100 mM for GABA) elicited large and desensitizing GABA B R-activated GIRK currents in DA neurons and small nondesensitizing currents in GABA neurons (Figure 2 ). All baclofen-activated currents were inhibited with the inwardly rectifying K + channel inhibitor Ba 2+ or the GABA B receptor antagonist (CGP 54626, not shown). In contrast to the sIPSC recordings, there was an $40% decrease in the GABA B R-GIRK currents of DA neurons 24 hr following a METH injection (Figures 2A and 2B ). However, this decrease in current was not apparent at 7 days following METH injection ( Figure 2B ). By contrast, the baclofen-activated GIRK (I Baclofen ) currents in GABA neurons were significantly depressed by $55% 24 hr following a single METH injection and the reduced I Baclofen persisted for 7 days ( Figures 2C and  2D ). We next examined whether METH altered GABA B R-GIRK signaling in other brain regions. There was no significant change in the sIPSC or I Baclofen in CA1 hippocampal pyramidal or GABAergic neurons 24 hr following METH ( Figure S1 available online). We also measured the sIPSC and I Baclofen in pyramidal and GABAergic neurons of the prelimbic cortex, a target region of VTA DA cells, and observed no significant changes in GABA B -GIRK currents in METH-injected mice ( Figure S1 ). Thus, a single exposure to METH triggered a profound and long-lasting depression in both the sIPSC and I Baclofen in GABA neurons of the VTA. In addition to postsynaptic GABA B receptors, presynaptic GABA B receptors are also involved in reducing GABA release, typically through inhibition of voltage-gated Ca 2+ channels (Padgett and Slesinger, 2010) . To investigate whether in vivo exposure to METH altered GABA B receptor-dependent presynaptic inhibition, we used an optogenetic strategy to selectively stimulate GABA neurons in the VTA and measure the effect of baclofen on a light-evoked fast inhibitory postsynaptic current (IPSC) recorded in DA neurons (Figure 3) . AAV virus expressing a double floxed-stopped channel rhodopsin 2 (ChR2)-eYFP was stereotaxically injected into the VTA of mice expressing Cre recombinase in GABA neurons (GAD65-Cre; Figure 3A ; Figure S2) . After 21 days, neurons expressing ChR2-eYFP were evident in horizontal slices of the VTA ( Figure S2A ). Prolonged blue light stimulation (400 ms) elicited tetrodotoxin (TTX)-insensitive photocurrents in GABA neurons, whereas short light pulses (4 ms) evoked picrotoxin-and TTX-sensitive fast IPSCs in DA neurons (Figures S2B and 2SC ; Figure 3B ). Bath application of baclofen (1 mM) depressed the light-evoked IPSC by $50% in saline-injected mice. By contrast, baclofen (1 mM) decreased the light-evoked IPSC by only $20% in METH-injected mice ( Figures 3B and 3C ). Construction of dose-response curves revealed that GABA B receptor-dependent inhibition of presynaptic release was shifted significantly to higher agonist concentrations ( Figure 3C ), reflected by an increase in the IC 50 , which is the concentration of Baclofen needed to inhibit 50% of the light-induced current ( Figure 3D ). Similar to the change in postsynaptic GABA B R-GIRK signaling, the reduced sensitivity of presynaptic GABA B Rs persisted for 7 days (Figures 3C and 3D) . As a control, we examined GABA B R-dependent presynaptic inhibition of glutamate release onto DA neurons by measuring the amplitude of electrically evoked AMPA EPSC, in the presence of increasing concentrations of baclofen ( Figure S3 ). We found no significant change in the IC 50 in METH-injected mice, compared to saline controls. Taken together, these results demonstrate that a single in vivo injection of METH triggers a depression in GABA B receptor signaling in VTA GABA neurons, both presynaptically (inhibition of GABA release) and postsynaptically (activation of GIRK channels).
Psychostimulant-Evoked Plasticity in GABA B R Involves Dopamine
Cocaine is another psychostimulant that rapidly elevates DA levels within minutes after the injection. In contrast to METH, which is taken up by DA neurons and stimulates reverse transport of DA through the dopamine transporter (DAT), cocaine inhibits DAT from the extracellular side (Sulzer, 2011) . We examined whether a single injection of cocaine would evoke a change in GABA B R-GIRK signaling. Like METH, cocaine (15 mg/kg) produced a significant decrease in the sIPSC in GABA neurons but not in DA neurons 24 hr later ( Figures 4A-4D ). Similarly, I Baclofen was depressed in GABA neurons but not in DA neurons ( Figures 4E-4H ). Thus, both cocaine and METH trigger a similar neuroadaptation in GABA B R-GIRK signaling in GABA neurons of the VTA, suggesting that elevated DA may be an important step in inducing the GABA B R-GIRK plasticity. Dopamine stimulates two classes of DA receptors, D1-and D2-like receptors, in the brain (White, 1996) . D1-like receptor antagonists block sensitization to psychostimulants (Kalivas and Stewart, 1991) , reduce self-administration of cocaine (Caine et al., 2007) , and prevent psychostimulant-induced changes in glutamatergic signaling in the VTA (Argilli et al., 2008; Brown et al., 2010) . To test the requirement for DA receptors, we injected an antagonist for D1-like (SCH39166) or D2-like (Eticlopride) receptors with METH ( Figure 5 ). In contrast to injection of METH alone, the sIPSC recorded from mice injected with METH and SCH39166 (0.3 mg/kg) was not significantly different from saline (Figures 5A and 5B) . By contrast, co-injection of Eticlopride (0.1 mg/kg) with METH did not attenuate the METH-dependent decrease in sIPSC. For macroscopic GABA B R-GIRK currents, co-injection of METH and SCH39166 also partially blocked the METH-dependent decrease in I Baclofen ( Figures 5C and 5D ). Interestingly, co-injection of Eticlopride with METH attenuated the METH-dependent decrease in I Baclofen (Figures 5C and 5D) , in contrast to the effect of Eticlopride on the sIPSC. This could reflect a difference in synaptically and extrasynaptically activated GABA B receptors. For cocaine, co-injection of METH or cocaine with both SCH39166 and Eticlopride partially recovered the sIPSC, compared to salineinjected controls ( Figures 5B and 5D ). Together, these pharmacological experiments clearly implicate DA and the D1-like receptor in mediating psychostimulant-dependent depression in GABA B R-GIRK signaling in VTA GABA neurons, similar to the plasticity changes in excitatory synapses in VTA DA neurons following cocaine (Argilli et al., 2008) .
Cellular Mechanism Underlying Depression of GABA B R-GIRK Signaling
A reduction in the amplitude of GABA B -GIRK currents could involve a change in G protein coupling (Nestler et al., 1990; Labouè be et al., 2007) , desensitization of GABA B receptors (Taniyama et al., 1991; Gonzá lez-Maeso et al., 2003) , and/or internalization of the receptor channel (Fairfax et al., 2004; Guetg et al., 2010; Maier et al., 2010; Terunuma et al., 2010) . To investigate the latter possibility, we used quantitative immuno-electron microscopy to study the subcellular distribution of GABA B receptors and GIRK channels in saline-and METH-injected mice. In serial ultrathin sections through the VTA, GABA neurons were identified using antibodies against GAD65/67 and secondary antibodies coupled to horseradish peroxidase (HRP), generating a dark reaction product in GABA neurons (Figures 6A and 6B) . VTA sections were also labeled with immunogold particles using specific antibodies for GABA B1 or GIRK2 (Kulik et al., 2003; Koyrakh et al., 2005) . In single ultrathin sections ( Figures 6A and 6B ), both GABA B1 and GIRK2 were expressed predominantly at the plasma membrane of GABA neuron dendrites (Den; arrows) following saline injection. By contrast, 24 hr following a METH injection, there was a reduction in plasma membrane associated GABA B1 and an increase at intracellular sites ( Figure 6A , crossed arrows). Similarly, there was a reduction in GIRK2 protein on the plasma membrane and an increase in intracellular compartments in GABA neurons following METH treatment ( Figure 6B ). To quantify these changes, we generated a three-dimensional reconstruction of the dendrite using the serial ultrathin sections (Figures 6C and 6D ) and then counted gold particles on the plasma membrane and in the cytoplasm. Calculating the surface and intracellular densities (Figures 6E and 6F) revealed that 24 hr following METH injection there was a significant reduction ($60%-70%) in plasma membrane-associated GABA B1 and GIRK2, with a concomitant increase in the intracellular-associated GABA B1 and GIRK2 ($50%-65%). By contrast, we did not observe a significant change in immunogold particle labeling of plasma membrane staining for GIRK2 and GABA B1 in GAD65/67-negative neurons (GIRK2: 0.924 ± 0.032 particles/ mm 2 saline versus 0.843 ± 0.054 METH, n = 21 and GABA B1:
1.042 ± 0.043 saline versus 0.922 ± 0.050 GABA B1 ; p > 0.05). Interestingly, the reduction in plasma membrane-associated GIRK2 and GABA B1 parallels the $50% depression in baclofeninduced GABA B R-GIRK currents ( Figure 2F ). Moreover, the relative decreases in GABA B1 and GIRK2 protein on the plasma membrane are very similar, suggesting the GABA B receptor and GIRK channel may internalize as a signaling complex from the plasma membrane (Boyer et al., 2009) . Taken together, these data demonstrate that 24 hr after a single injection of METH, both GABA B receptor and GIRK channel protein levels are reduced on the plasma membrane of GABA neurons, providing a reasonable explanation for depressed GABA B R-GIRK currents in those neurons. The quantitative immunogold electron microscopy data suggested that METH treatment induced internalization of the receptor and channel. The phosphorylation status of the GABA B receptor is important for regulating surface expression of the receptor (Fairfax et al., 2004; Koya et al., 2009; Guetg et al., 2010; Terunuma et al., 2010) . We therefore examined whether phosphorylation of the GABA B receptor could play a role in mediating the METH-dependent depression. We examined the phosphorylation of S783 (p-S783) in GABA B2 because dephosphorylation is associated with reduced surface expression of GABA B receptors in neurons (Terunuma et al., 2010) . Protein isolated from tissue punches of the VTA, NAc, hippocampus, or mPFC from saline-and METH-injected mice (24 hr) were examined using a phospho-specific antibody for phosphorylated S783 in GABA B2 (Dobi et al., 2010) . Remarkably, METH injection led to a $25% reduction in phosphorylation of GABA B2 -S783 in the VTA ( Figure 7A ). This change in p-S783 compares to a METH-induced $50% reduction in I Baclofen in GABA neurons ( Figure 2D ). However, the VTA tissue punches contain a mixture of cell types that express GABA B receptors, which likely account for the smaller change in GABA B2 -p-S783. By contrast, there was no change in GABA B2 -p-S783 in the NAc, mPFC, or hippocampus from METH -injected mice ( Figures  7B-7D) . Examination of p-S892, a different phosphorylation site on GABA B2 (Fairfax et al., 2004) , revealed no change in phosphospecific labeling of GABA B2 -p-S892 in METH-injected mice, indicating the effect of METH was unique to GABA B2 -S783 ( Figure 7E ). Lastly, there was no apparent change in the levels of GABA B2 receptor protein ( Figure 7F ), suggesting little METH-dependent degradation of receptor.
Dephosphorylation of GABA B2 -p-S783 has been previously shown to be regulated by protein phosphatase 2A (PP2A; Terunuma et al., 2010) , raising the possibility that in vivo exposure to METH enhances the phosphatase activity in VTA GABA neurons. To address this, we examined the effect of acutely inhibiting PP1/PP2A phosphatases with okadaic acid (OA; 100 nM). In saline-injected mice, there was no significant difference in the amplitude of I Baclofen with OA in the pipet, suggesting that basal activity of PP1/PP2A does not significantly regulate GABA B R-GIRKs (Figures 7G-7J) . In METH-injected mice, however, intracellular application of OA promoted recovery of the I Baclofen ( Figures 7H and 7J) . Note the slow time course of activation for I Baclofen in the presence of OA in METH-injected mice. This increase could reflect insertion of GABA B receptors and GIRK channels on the plasma membrane or restoration of functional G protein coupling. For control, we examined the effect of PKC(19-36), a peptide inhibitor of PKC ( Figure 7K ). Unlike OA, the presence of PKC inhibitor in the pipet did not restore I Baclofen , similar to the effect of METH alone. Taken together, these findings suggest that in vivo exposure to METH triggers a phosphatase-dependent downregulation of GABA B Rs and GIRK channels from the plasma membrane of GABA neurons, which results in reduced GABA B R-GIRK signaling and accumulation of GABA B receptor complexes in intracellular compartments. 
Loss of GABA B R-Dependent Inhibition of VTA GABA Neuron Firing
To investigate the functional consequence of reduced GABA B R-GIRK currents in GABA neurons of METH-injected mice, we examined the effect of baclofen on the induced firing rate of GABA neurons (Figure 8) . We predicted that a loss of GABA B R-GIRK signaling would attenuate GABA B R-mediated suppression of firing in GABA neurons. To test this, a series of current steps (20-100 pA) were injected to elicit a train of action potentials in GABA neurons ( Figures 8A and 8B) . In saline-and METH-injected mice, the input-output (I-O) plot shows a linear increase in firing rate with larger current injections ( Figures 8B  and 8D ). As expected, baclofen (100 mM) significantly suppressed firing in GABA neurons of saline-injected mice, decreasing the slope of the I-O curve ( Figures 8A and 8B) . By contrast, a saturating dose of baclofen (100 mM) did not significantly change the I-O curve in METH-injected mice ( Figures 8B  and 8C ). These results demonstrate that a loss of GABA B R-GIRK currents in GABA neurons removes an important ''brake'' on GABA neuron firing in the VTA.
DISCUSSION
Drug-evoked synaptic plasticity can cause persistent modifications of neural circuits that eventually lead to addiction. We report here that a single dose of METH or cocaine is sufficient to significantly weaken the ability of GABA B receptors to control VTA GABA neuron firing when measured ex vivo 24 hr later. As such, this adaptive change is not likely sufficient to cause addiction but rather represents a building block of the adaptations that underlie addictive behavior with repetitive exposure. Studying the effect of a single injection of drug enabled us to systematically probe the mechanism underlying the plasticity of the slow IPSC. We discovered the methamphetamine-induced loss of the slow IPSC arises from a reduction in the GABA B R-GIRK currents, due to changes in protein trafficking, and is accompanied by a significant decrease in the sensitivity of presynaptic GABA B receptors in GABA neurons of the VTA. In contrast, GABA neurons of the hippocampus and prelimbic cortex did not show similar changes in GABA B -GIRK signaling, suggesting the GABA B Rs in the VTA are uniquely targeted by psychostimulants.
The psychostimulant-evoked reduction of GABA B -GIRK currents in VTA GABA neurons could arise from a change in G protein coupling (Nestler et al., 1990; Labouè be et al., 2007) or internalization of the receptor-channel (Gonzá lez-Maeso et al., Fairfax et al., 2004; Guetg et al., 2010; Maier et al., 2010; Terunuma et al., 2010) . In support of the latter possibility, quantitative immunogold electron microscopy revealed a significant reduction in surface expression of GABA B receptors and GIRK channels in GABA neurons of METH-injected mice, coincident with a decrease in phosphorylation of GABA B Rs. In cortical and hippocampal neurons, a balance of AMP-activated protein kinase (AMPK)-dependent phosphorylation of GABA B2 -S783 and PP2A-dependent dephosphorylation governs postendocytic sorting of GABA B receptors (Terunuma et al., 2010) . The persistence of the GABA B -GIRK depression and the rapid recovery with phosphatase inhibitors suggest the balance of surface and internalized GABA B receptors in GABA neurons might be controlled by a molecular switch in a phosphatase, perhaps akin to the autophosphorylation switch in CaMKII (Lucchesi et al., 2011) or through an endogenous regulator of protein phosphatase activity (Guo et al., 1993) . It remains possible that other kinases are also involved; both PKA-and CaMKII-dependent phosphorylation have been implicated in stabilization of GABA B1 on the plasma membrane (Couve et al., 2002; Guetg et al., 2010) . Interestingly, total protein levels of GABA B2 receptors were not significantly changed in METH-injected mice, suggesting that the internalized pool of receptors was not redirected to a degradation pathway, in contrast to activity-dependent degradation of GABA B receptors observed in cortex (Terunuma et al., 2010) . If phosphorylation controls surface expression of GABA B receptors, then what controls the surface expression of GIRK channels? CaMKII-dependent phosphorylation of GIRK2 has been implicated in stabilizing GIRK2 channels on the plasma membrane of hippocampal neurons (Chung et al., 2009) . In these neurons, protein phosphatase-1-mediated dephosphorylation promotes GIRK channel recycling and increases surface expression (Chung et al., 2009 ); therefore, a phosphatase inhibitor would be expected to reduce GIRK expression on the plasma membrane. An alternative explanation is that GIRK channels internalize via association with GABA B receptors in a macromolecular signaling complex. Previous studies have shown that both GPCRs and GIRK channels are physically close (Lavine et al., 2002; Nobles et al., 2005; Riven et al., 2006; Fowler et al., 2007) and can traffic together through intracellular compartments (Clancy et al., 2007) .
Psychostimulants, such as METH and cocaine, generally lead to elevations in DA (Sulzer, 2011) that signals through two classes of GPCRs, D1-and D2-like receptors. Activation of D1-like receptors is required for inducing locomotor sensitization (Kalivas and Stewart, 1991) , establishing self-administration of cocaine (Caine et al., 2007) , and potentiating excitatory synapses with psychostimulants (Argilli et al., 2008; Brown et al., 2010) . Supporting a role for D1-like receptors, co-injection of a D1-like receptor antagonist significantly attenuated the psychostimulant-dependent depression of GABA B R-GIRK currents in VTA GABA neurons. We also observed some effects of the D2-like antagonist and cannot completely rule out a component of D2-like receptor activation in the depression of GABA B -GIRK signaling. Recently, an acute cocaine-induced weakening of baclofen-induced GIRK currents in VTA DA neurons was found to be sensitive to D2-like, but not D1-like, receptor antagonists (Arora et al., 2011) . In addition to DA, other neurotransmitters may be involved in the psychostimulant-dependent depression of GABA B R-GIRK signaling. For example, acetylcholine levels in the VTA also increase following a single METH injection (Dobbs and Mark, 2008) , and neuropeptides, such as hypocretin/orexin, BDNF, and CRF, could be also involved in the response to addictive drugs (Wang et al., 2005; Borgland et al., 2006; Hyman et al., 2006; Pu et al., 2006) . Conditional knockouts or selective pharmacological experiments will be needed to pinpoint the neurotransmitters involved in the (A and B) Pre-embedding double-labeling electron microscopy reveals GABA B1 and GIRK2 expression in GABAergic neurons of the VTA 24 hr following saline or METH injection. GABA neurons were identified by GAD65/ 67-HRP immunoreactivity (labeled Den). Immunogold particles identify GABA B1 or GIRK2. A reduction in immunogold particles against GIRK2 or GABA B1 along the plasma membrane (arrows) was clearly detected in GAD65/67 positive dendrites following METH injection; an increase in immunogold particles against GIRK2 and GABA B1 at intracellular sites can also be seen (crossed arrows). Right panels in (A) and (B) show zoom of boxed area. Den, dendrite; ax, axon; mit, mitochondria. Scale bars: 0.5 mm.
(C) and (D) Three-dimensional reconstructions of dendrites from serial electron micrographs. Note decrease in surface expression of GABA B1 receptors (C) and GIRK2 (D) following METH treatment. Black dots represent immunogold particles on the front surface and gray dots show immunogold particles on the back side of the dendrite. Blue regions are excitatory synapses. Note immunogold particles are abundantly distributed over the dendritic plasma membrane in control mice. Scale bars: 0.5 mm.
(E and F) Bar graphs show quantification of immunogold particles in reconstructed GAD65/67-positive dendrites for plasma membrane associated (GABA B1 saline: 16.0 ± 2.7; GABA B1 METH: 4.8 ± 0.8; GIRK2 saline: 14.1 ± 2.6; GIRK2 METH: 5.3 ± 1.0 particles/mm 3 ) and intracellular particles (GABA B1 saline: 15 ± 3.6; GABA B1 METH: 29.9 ± 6.2; GIRK2 saline: 20.7 ± 2.6; GIRK2 METH: 62.3 ± 10.5 particles/mm 3 ). Immunogold particles against both GABA B1 and GIRK2 are significantly reduced at the dendritic plasma membrane and increased at intracellular sites 24 hr after METH injection (**p < 0.05 [Student t test]).
Neuron
Depression of GABA B R-GIRKs with Psychostimulants psychostimulant-dependent depression of GABA B R-GIRK responses in VTA GABA neurons. How may the psychostimulant-evoked depression in GABA B -GIRK signaling in VTA GABA neurons alter the physiology of the VTA and contribute to addiction? DA neurons fire in two modes, tonic and phasic, with phasic firing leading to higher DA levels (Cooper, 2002) . A balance of NMDAR activation and GABA B R signaling controls tonic versus phasic firing, and activation of GABA B receptors plays an important role in reducing phasic firing in VTA DA neurons (Erhardt et al., 2002) . The VTA GABA neurons provide a local source of GABA for controlling the firing of VTA DA neurons (Grace and Bunney, 1985; Johnson and North, 1992; Tan et al., 2010) . Recent electron microscopy studies have confirmed synaptic contacts between local GABA and DA neurons within the VTA (Omelchenko and Sesack, 2009 ). In the present study, we demonstrate the functionality of these GABAergic synapses using optogenetic tools. The depression of GABA B R-GIRK signaling in somatodendritic regions along with the reduced sensitivity of GABA B Rs in presynaptic GABA terminals of VTA GABA neurons would markedly impair an intrinsic ''brake'' on GABA release several days after a single injection of METH. Together, these pre-and postsynaptic neuroadaptations are predicted to increase GABA-mediated inhibition of VTA DA neurons. In line with this model, other groups have reported psychostimulant-evoked neuro-adaptations in GABA B Rsignaling that lead to enhanced GABAergic transmission in the VTA (Giorgetti et al., 2002) , the dorsolateral septal nucleus (Shoji et al., 1997) , and the NAc (Xi et al., 2003) . Similarly, chronic morphine increases the sensitivity of GABA B receptors on glutamatergic terminals in the VTA, which would further enhance the inhibition of DA neurons mediated by augmented GABA release (Manzoni and Williams, 1999 ).
An enhanced GABAergic inhibition of VTA DA neurons may represent an attempt to restore balance in activity of the VTA circuit; therefore, this GABA B R-GIRK adaptation may be considered a form of synaptic scaling. Neuro-adaptive changes in GABA B R-GIRK signaling for re-establishing balance in neural circuits have been described in other model systems. In a mouse model of succinic semialdehyde dehydrogenease deficiency, an autosomal recessive disorder of GABA catabolism that leads to elevated synaptic GABA, GABA B R-GIRK currents are significantly depressed in cortical neurons (Vardya et al., 2010) . On the other hand, the GABA B R-mediated IPSC in hippocampal pyramidal neurons is enhanced in response to potentiation of excitatory synaptic transmission (Huang et al., 2005) . The level of inhibition mediated by GABA B R-GIRK currents may be tightly tuned to changes in neuronal excitability.
The downregulation of GABA B receptor signaling in VTA GABA neurons occurs in parallel with other plastic changes in VTA DA neurons, such as the redistribution of AMPAR and NMDARs (White et al., 1995; Zhang et al., 1997; Ungless et al., 2001; Borgland et al., 2004; Argilli et al., 2008; Mameli et al., 2011) , and alterations of fast GABAergic transmission (Nugent et al., 2007) . As proposed above, the drug-evoked depression of GABA B R signaling in GABA neurons removes a ''brake'' on GABA neuron firing that may enhance GABAmediated inhibition of DA neurons. If present in vivo, the increase in GABA transmission may reduce reward perception (Koob and Volkow, 2010; Lü scher and Malenka, 2011) . However, repeated psychostimulant administration leads to increases in the firing rates of VTA DA neurons (White and Wang, 1984; Henry et al., 1989; White, 1996) , partly through reduced sensitivity of D2 autoreceptors (White, 1996) . Thus, an increase in GABA-mediated inhibition of VTA DA neurons, whereas efficient at first, may eventually be inadequate to suppress the potentiating effects of psychostimulants on VTA DA neurons and is therefore unable to avert the progression toward addiction. Enhancing this inhibitory pathway, however, might provide a strategy for treating addiction. Clearly, additional experiments will be needed to better understand how the adaptation of GABA B R-GIRK signaling affects VTA GABA neuron function and, more generally, the role of the slow GABA B -mediated inhibition in drug-evoked remodeling of the mesocorticolimbic circuitry.
In conclusion, we have identified a molecular switch in GABA B receptor signaling that occurs in response to a single in vivo exposure to psychostimulant-this depression of GABA B R-GIRK signaling persists for days after the injection. This cellular memory trace of drug exposure is encoded in a phosphorylation-dependent depression of GABA B receptor signaling in VTA GABA neurons, which may augment GABA transmission in the mesocorticolimbic system. EXPERIMENTAL PROCEDURES Animals C57BL/6 mice were purchased from Harlan laboratories or bred in-house and housed under constant temperature and humidity on a 12 hr light-dark cycle (light 6 am-6 pm) with free access to food and water. GAD67-GFP is a knock-in mouse that was kindly provided by Dr. Y. Yanagawa. Pitx3-GFP is a knock-in mouse that was kindly provided by Dr. M. Li. All procedures were performed in the light cycle using IACUC approved protocols for animal handling at the Salk Institute and the University of Geneva.
Drug Treatment
Male and female mice (P15-35) were injected intraperitoneally with 0.9% saline (control), 2 mg/kg methamphetamine (METH), or 15 mg/kg cocaine using a 15-gauge insulin syringe and injection volume <200 ml to minimize stress. Experimental procedures were performed 24 hr-7 days later. Methamphetamine and cocaine were purchased from Sigma (St. Louis, MO, USA).
Electrophysiology in Acute Slices
Twenty-four hours or 7 days following i.p. injections, mice were euthanized and horizontal slices from midbrain (250 mm) were prepared in ice-cold artificial cerebral spinal fluid (see Supplemental Experimental Procedures for details). Neurons were visualized with IR camera Gloor Instrument PCO or Dage-MTI IR-1000) on an Olympus scope (BX50 or BX51) and whole-cell patch-clamp recordings (Axopatch 200B or Multiclamp 700A amplifier) were made from neurons in the VTA, identified as the region medial to the medial terminal nucleus of the accessory optical tract. GABA neurons were identified by the absence of I h current, a small capacitance (<20 pF) and a fast spontaneous firing rate (5-10 Hz). In contrast DA neurons have an I h current, large capacitance (20-50 pF) and slow spontaneous firing (1-3 Hz). Pitx3-GFP mice expressing GFP in DA neurons (Zhao et al., 2004) and GAD67-GFP mice expressing GFP in GABA neurons (Tamamaki et al., 2003) were used to confirm electrophysiological identification. The internal solution for measuring baclofen-activated GABA B currents contained (in mM) potassium gluconate 140, NaCl 4, MgCl 2 2, EGTA 1.1, HEPES 5, Na 2 ATP 2, sodium creatine phosphate 5 and Na 3 GTP 0.6 (pH 7.3) with KOH. For GABA B sIPSCs, the internal solution contained (in mM) K-gluconate 140, KCl 5, MgCl 2 2, EGTA 0.2, HEPES 10, Na 2 ATP 4, Creatine-phosphate 10, and Na 3 GTP 0.3. To measure GABA A currents, the internal solution contained (in mM) K-gluconate 30, KCl 100, MgCl 2 4, creatine phosphate 10, Na 2 ATP 3.4, Na 3 GTP 0.1, EGTA 1.1, and HEPES 5.
For the sIPSC, the evoked synaptic recordings were isolated in presence of APV (100 mM), NBQX (10 mM), and sulpiride (200 nM) for GABA A R IPSC, and picrotoxin (100 mM) for GABA B R sIPSC. The stimulation electrode consisted of a saline-filled monopolar glass pipet placed caudally to the cell being recorded. GABA A R paired-pulse ratio (PPR) was assessed by applying two pulses at 50 ms interval every 10 s, whereas the GABA B R sIPSCs were evoked by applying a train of 10 electrical pulses at 66Hz once every 20-40 s. For I Baclofen , currents were recorded, filtered at 1 kHz and digitized at 5 kHz (Axon pClamp 8). Cells were clamped at À50 or À60 mV (membrane voltages were corrected for liquid junction potential; À15.7 mV). For some recordings, a voltage ramp from +60 mV to À100 mV was delivered at 1 Hz. Cell membrane resistance and approximate access resistance were measured with a 200 ms 10 mV hyperpolarizing step. All electrophysiological chemicals for electrophysiology were purchased from Sigma; drugs were purchased from Tocris Bioscience (Minneapolis, MN). We did not observe any differences with wild-type mice and Pitx3-GFP or GAD67-GFP; therefore, we have pooled the data. Data are expressed as mean ± SEM and statistical significance (p < 0.05) determined by one-way analysis of variance (ANOVA) with Holm-Sidak post hoc test, Student's t test, or Mann-Whitney test. All measurements made at $33 C.
Optogenetic Experiment AAV5-flox-ChR2-eYFP virus (produced in the Vector Core Facility at the University of North Carolina) was injected into 3-week-old GAD65-Cre mice (kindly provided by Dr. Gero Miesenbö ck). Anesthesia was induced and maintained with isoflurane (Baxter AG, Vienna, Austria) at 5% and 1%, respectively. The animal was placed in a stereotaxic frame (Angle One; Leica, Solms, Germany) and craniotomies were performed bilaterally over the VTA using stereotaxic coordinates (AP À3.4, ML ± 0.8, and DV 4.4). Injections of AAV-ChR2 flox were carried out using graduated pipets (Drummond Scientific Company, Broomall, PA, USA), broken back to a tip diameter of 10-15 mm, at a rate of $100 nl min -1 for a total volume of 500 nl. In all experiments the virus was allowed 3 weeks to incubate before any other procedures were carried out. Fast GABA A IPSCs in DA cells were isolated in presence of kynurenic acid (2 mM) and evoked by applying two consecutive 4 ms blue-light (Thorlad-472 nm LED) flashes at 50 ms interval to the slice every 10 s. Recordings were made as described previously. 
Immunoelectron Microscopy
A similar procedure to that described earlier (Lujan et al., 1996; Koyrakh et al., 2005) was used. See online Supplemental Experimental Procedures for details on procedures and quantitation.
Western Blotting
Tissue punches from VTA, NAc, hippocampus, and mPFC obtained from saline-and METH-injected mice were lysed in 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 10 mM NaF, 2 mM Na 3 VO 4 , 10 mM Na 4 P 2 O 7 , 10 mg/ml leupeptin, 1 mg/ml aprotinin, 10 mg/ml antipain, and 250 mg/ml 4-(2-Aminoethl) benzenesulfonyl fluoride hydrochloride. Soluble material was then subjected to immunoblotting with anti-GABA B2 , anti-phospho S783-GABA B2 (p-S783), anti-phospho S892-GABA B2 (p-S892), anti-GAPDH, and detected by SuperSignal West Dura Chemiluminescent Substrate (Thermo Scientific, Rockford, IL, USA). The luminescence images were captured by a Luminescent Image Analyzer (LAS3000; Fujifilm, Tokyo, Japan) and the intensity of bands were measured by Multi Gauge software (version 3; Fujifilm).
SUPPLEMENTAL INFORMATION
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